Microbot Medical Inc. MBOT
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 101.63% | 83.17% | 67.24% | 60.32% | 38.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.92% | 31.68% | 26.82% | 36.75% | 41.73% |
| Operating Income | -37.35% | -30.83% | -26.82% | -36.75% | -41.73% |
| Income Before Tax | -28.57% | -21.75% | -14.85% | -16.64% | -21.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.57% | -21.75% | -14.85% | -16.64% | -21.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.57% | -21.75% | -14.85% | -16.64% | -21.77% |
| EBIT | -37.35% | -30.83% | -26.82% | -36.75% | -41.73% |
| EBITDA | -37.78% | -31.30% | -27.41% | -37.48% | -42.38% |
| EPS Basic | 53.78% | 56.94% | 57.99% | 43.33% | 29.37% |
| Normalized Basic EPS | 54.58% | 57.59% | 56.59% | 34.29% | 18.68% |
| EPS Diluted | 53.78% | 56.94% | 57.99% | 43.33% | 29.37% |
| Normalized Diluted EPS | 54.58% | 57.59% | 56.59% | 34.29% | 18.68% |
| Average Basic Shares Outstanding | 146.68% | 175.21% | 192.46% | 132.21% | 93.01% |
| Average Diluted Shares Outstanding | 146.68% | 175.21% | 192.46% | 132.21% | 93.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |